
Each market cycle is unique — shouldn’t your metrics be unique too? Matt Caruso, president of Caruso Insights, joins Investor’s Business Daily’s “Investing with IBD” podcast to discuss how the market rewards different winning stocks depending on its cycle. Learn about the critical metrics to analyze each time, and why AI adjacent names Palantir (PLTR) and GE Vernova (GEV) deserve a closer look alongside mainstays like Nvidia (NVDA) and Tesla (TSLA). Check out our daily newsletter! https://get.investors.com/marketdiem/ Get more IBD by subscribing to our channel: https://www.youtube.com/@investorsbusinessdaily Visit our website: https://www.investors.com Like us on Facebook: https://www.facebook.com/investorsbusinessdaily Follow us on Twitter: https://twitter.com/IBDinvestors Follow us on Instagram: https://www.instagram.com/investorsbusinessdaily/ Follow us on StockTwits: https://stocktwits.com/InvestorsBusinessdaily Follow us on LinkedIn: https://www.linkedin.com/company/investors-business-daily Follow us on TikTok: https://www.tiktok.com/@ibdinvestors Investor’s Business Daily has been helping people invest smarter results by providing exclusive stock lists, investing data, stock market research, education and the latest financial and business news to help investors make more money in the stock market. #InvestorsBusinessDaily #IBD

Prepare Your Portfolio For The Future By Finding Past Market Analogies | Investing with IBD

Protect Your AI Bets From Destruction: Why Hedging Matters For All Traders | Investing with IBD

Matt Caruso: Learning To Exit Weak Plays Faster | Investing With IBD

Matt Caruso: Knowing Your Tools For Success | Investing With IBD